Stem cell extracellular vesicles and kidney injury

Area of Science:

• Regenerative Medicine
• Cell Biology
• Nephrology

Background:

• Extracellular vesicles (EVs) are emerging as a potent cell-free therapeutic strategy for renal diseases.
• EVs derived from stem cells, particularly mesenchymal stromal cells (MSCs), can replicate the regenerative properties of their parent cells.
• These vesicles contain bioactive molecules like proteins and RNA that modulate cellular processes.

Purpose of the Study:

• To review the application of stem cell-derived EVs in preclinical models of acute and chronic kidney injury.
• To compare different aspects of EV therapy, including cell origin, EV sub-fractions, dosage, and administration routes.
• To evaluate the efficacy of EVs in promoting renal recovery and graft preservation.

Main Methods:

• Literature review of preclinical studies on stem cell-derived EVs for kidney diseases.
• Analysis of studies using various animal models of kidney injury.
• Comparison of EVs from different stem cell sources and their sub-fractions.
• Evaluation of different administration routes and dosages.

Main Results:

• EVs from MSCs demonstrate significant regenerative potential in various kidney injury models.
• EVs stimulate target cell proliferation and angiogenesis while reducing apoptosis and inflammation.
• Pre-transplant perfusion with EVs shows promise for kidney graft conditioning.

Conclusions:

• Stem cell-derived EVs represent a promising cell-free therapeutic approach for acute and chronic kidney diseases.
• Further research is warranted to optimize EV-based therapies for clinical application in nephrology.
• EVs hold potential for both direct treatment of renal damage and ex vivo kidney graft enhancement.